Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 5/2016

01-10-2016 | Case Report

Crimean–Congo haemorrhagic fever: transmission to visitors and healthcare workers

Authors: T. Yildirmak, N. Tulek, C. Bulut

Published in: Infection | Issue 5/2016

Login to get access

Abstract

Crimean–Congo haemorrhagic fever is a viral haemorrhagic disease, mostly transmitted by tick bites or through contact with infected animal’s blood, and bodily fluids. Nosocomial infections were occasionally reported in healthcare settings. We report nosocomial cluster of Crimean–Congo haemorrhagic fever including the visitor with unknown transmission.
Literature
1.
Bente DA, Forester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M. Crimean–Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antivir Res. 2013;100:159–89.CrossRefPubMed
2.
Ergonul O. Crimean–Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol. 2012;2:215–20.CrossRefPubMed
3.
Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, et al. The epidemiology of Crimean–Congo hemorrhagic fever in Turkey, 2002–2007. Int J Infect Dis. 2009;13:380–6.CrossRefPubMed
4.
Celikbas AK, Dokuzoğuz B, Baykam N, Gok SE, Eroğlu MN, Midilli K, et al. Crimean–Congo hemorrhagic fever among health care workers, Turkey. Emerg Infect Dis 2014. doi:10.​3201/​eid2003.​131353
5.
6.
Mardani M, Rahnavardi M, Rajaeinejad M, Naini KH, Chinikar S, Pourmalek F. Crimean–Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions. Am J Trop Med Hyg. 2007;76:443–5.PubMed
7.
Tütüncü EE, Gurbuz Y, Ozturk B, Kuscu F, Sencan I. Crimean–Congo haemorrhagic fever, precautions and ribavirin prophylaxis: a case report. Scand J Infect Dis. 2009;41:378–80.CrossRefPubMed
8.
Pshenichnaya Y, Nenadskaya SA. Probable Crimean–Congo hemorrhagic fever virus transmission occurred after aerosol-generating medical procedures in Russia: nosocomial cluster. Int J Infect Dis. 2015;33:120–2.CrossRefPubMed
9.
Duh D, Saksida A, Petrovec M, Ahmeti S, Dedushaj I, Panning M. Viral load as predictor of Crimean–Congo hemorrhagic fever outcome. Emerg Infect Dis. 2007;13:1769–72.CrossRefPubMedPubMedCentral
10.
Wong G, Liu W, Liu Y, Zhou B, Bi Y, Gao GF. MERS, SARS, and Ebola: the role of super-spreaders in infectious disease. Cell Host Microbe. 2015;18:398–401.CrossRefPubMed
Metadata
Title
Crimean–Congo haemorrhagic fever: transmission to visitors and healthcare workers
Authors
T. Yildirmak
N. Tulek
C. Bulut
Publication date
01-10-2016
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2016
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0923-x

Other articles of this Issue 5/2016

Infection 5/2016 Go to the issue

Review

Occult HBV infection in the oncohematological setting

Review

Neurotoxocariasis: a systematic literature review

Original Paper

Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas

Original Paper

Antibiotic stewardship in a tertiary care hospital of a developing country: establishment of a system and its application in a unit—GASP Initiative

Original Paper

Clinical prognostic factors for time to positivity in cancer patients with bloodstream infections

Original Paper

A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits